AGEN

Agenus to Report Fourth Quarter and Year End 2013 Financial Results on March 5, 2014; Conference Call to Follow

[Business Wire] – Agenus Inc. will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014. moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Agenus (AGEN) in Focus: Stock Up 6.9%

moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Agenus Completes Acquisition of 4-Antibody

[Business Wire] – Agenus Inc. , a biopharmaceutical company developing novel immunotherapeutics, including a portfolio of checkpoint modulators , anti-cancer vaccines and adjuvan moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Academic Support Boosts Agenus And Prophage G-200

moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Agenus to Report First Quarter 2013 Financial Results on April 24, 2013; Conference Call to Follow

[at noodls] – Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [email protected] 617-818-2985 Lexington, MA – April 18, 2013 – Agenus Inc. (NASDAQ: … moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Agenus Eliminates its $39 Million Senior Notes and Completes $10 Million of New Debt Financing

[at noodls] – Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [email protected] 617-818-2985 Agenus Eliminates its $39 Million Senior Notes and Completes … moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Agenus to Present at the Roth Annual Conference

[at noodls] – Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [email protected] 617-818-2985 AGENUS TO PRESENT AT THE ROTH ANNUAL CONFERENCE Lexington, … moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboardSee who Agenus is hiring next, click here to view […]

Efficacy Shown With Glaxosmithkline’s Phase 3 Malaria Vaccine Candidate, Which Contains Agenus’ QS-21 Stimulon Adjuvant

[at noodls] – Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [email protected] 617-818-2985 EFFICACY SHOWN WITH GLAXOSMITHKLINE’S PHASE 3 MALARIA … moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboard […]

Agenus to Report 3rd Quarter Financial Results on October 25, 2012; Conference Call to Follow

[at noodls] – Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [email protected] 617-818-2985 Agenus to Report 3rd Quarter Financial Results on October … moreView todays social media effects on AGENView the latest stocks trending across Twitter. Click to view dashboard […]